SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001104659-20-101751
Filing Date
2020-09-02
Accepted
2020-09-02 13:31:35
Documents
33

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 18014
2 PART II AND III tm2024664-6_1aa.htm PART II AND III 1687493
3 EXHIBIT 6.1 tm2024664d7_ex6-1.htm EX1A-6 MAT CTRCT 64029
4 EXHIBIT 6.2 tm2024664d7_ex6-2.htm EX1A-6 MAT CTRCT 72035
5 EXHIBIT 6.3 tm2024664d7_ex6-3.htm EX1A-6 MAT CTRCT 263462
6 EXHIBIT 6.4 tm2024664d7_ex6-4.htm EX1A-6 MAT CTRCT 88737
7 EXHIBIT 6.5 tm2024664d7_ex6-5.htm EX1A-6 MAT CTRCT 391969
8 EXHIBIT 6.6 tm2024664d7_ex6-6.htm EX1A-6 MAT CTRCT 312549
9 EXHIBIT 6.8 tm2024664d7_ex6-8.htm EX1A-6 MAT CTRCT 24225
10 EXHIBIT 6.9 tm2024664d7_ex6-9.htm EX1A-6 MAT CTRCT 24919
11 EXHIBIT 6.14 tm2024664d7_ex6-14.htm EX1A-6 MAT CTRCT 299726
12 EXHIBIT 6.17 tm2024664d1_ex6-17.htm EX1A-6 MAT CTRCT 374970
13 EXHIBIT 11.1 tm2024664d7_ex11-1.htm EX1A-11 CONSENT 2651
14 GRAPHIC lg_scopus-pn.jpg GRAPHIC 2106973
15 GRAPHIC tm2024664d7_ex6-2img01.jpg GRAPHIC 29707
16 GRAPHIC tm2024664d7_ex6-2img02.jpg GRAPHIC 10336
17 GRAPHIC tm2024664d7_ex6-2img03.jpg GRAPHIC 3353
18 GRAPHIC tm2024664d7_ex6-2img04.jpg GRAPHIC 16223
19 GRAPHIC tm2024664d7_ex6-2img05.jpg GRAPHIC 10814
20 GRAPHIC tm2024664d7_ex6-2img06.jpg GRAPHIC 12997
21 GRAPHIC tm2024664d7_ex6-2img07.jpg GRAPHIC 8440
22 GRAPHIC tm2024664d7_ex6-2img08.jpg GRAPHIC 9368
23 GRAPHIC tm2024664d7_ex6-2img09.jpg GRAPHIC 141778
24 GRAPHIC tm2024664d7_ex6-2img10.jpg GRAPHIC 7293
25 GRAPHIC tm2024664d7_ex6-2img11.jpg GRAPHIC 26227
26 GRAPHIC tm2024664d7_ex6-2img12.jpg GRAPHIC 7339
27 GRAPHIC tm2024664d7_ex6-2img13.jpg GRAPHIC 21066
28 GRAPHIC tm2024664d7_ex6-2img14.jpg GRAPHIC 8402
29 GRAPHIC tm2024664d7_ex6-2img15.jpg GRAPHIC 10134
30 GRAPHIC tm2024664d7_ex6-2img16.jpg GRAPHIC 121745
31 GRAPHIC tm2024664d7_ex6-4img01.jpg GRAPHIC 7913
32 GRAPHIC tm2024664d7_ex6-4img02.jpg GRAPHIC 1987
33 GRAPHIC tm2024664d1_ex6-17img01.jpg GRAPHIC 11639
  Complete submission text file 0001104659-20-101751.txt   6639512
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11228 | Film No.: 201156418
SIC: 2834 Pharmaceutical Preparations